CRISP1

Across TCGA pan-cancer cohorts, CRISP1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CRISP1 data layer compared with 15 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CRISP1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CRISP1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC, UCEC, and SKCM are the cancer types where CRISP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.153	0.604	.002	27	view →
UCEC	DFS	Median	All	1.000	0.630	.033	10	view →
SKCM	DFS	Median	All	0.364	0.642	.037	7	view →
LIHC	OS	Median	III,IV	0.198	0.648	.021	6	view →
LUSC	OS	Median	III,IV	0.292	0.669	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CRISP1–HNSC (DFS)

Open the HNSC breakdown →